Galectin-3 May Be a Biomarker for Cardiovascular Disease in RA

Galectin-3 may have potential as a biomarker for the early onset of cardiovascular disease in RA patients, potentially enabling early intervention and deferring the cardiovascular risks associated with RA...

Source: The Rheumatologist - March 25, 2019 Category: Rheumatology Authors: Carina Stanton Tags: Conditions Rheumatoid Arthritis cardiovascular Cardiovascular disease galectin‐3 Rheumatoid Arthritis (RA) risk Source Type: research